X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (58182) 58182
Newsletter (1166) 1166
Newspaper Article (868) 868
Book Chapter (316) 316
Magazine Article (145) 145
Transcript (122) 122
Publication (12) 12
Book / eBook (11) 11
Book Review (10) 10
Conference Proceeding (7) 7
Trade Publication Article (7) 7
Reference (5) 5
Dissertation (4) 4
Report (3) 3
Government Document (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46783) 46783
female (23983) 23983
male (21165) 21165
middle aged (16717) 16717
antibodies, monoclonal - therapeutic use (14598) 14598
adult (14401) 14401
aged (12104) 12104
antibodies, monoclonal - adverse effects (12005) 12005
animals (11814) 11814
oncology (11354) 11354
treatment outcome (11148) 11148
monoclonal antibodies (10573) 10573
immunology (8026) 8026
cancer (7496) 7496
antibodies, monoclonal, humanized (7067) 7067
care and treatment (7063) 7063
therapy (6939) 6939
antibodies (6867) 6867
antibodies, monoclonal - administration & dosage (6500) 6500
immunotherapy (5734) 5734
monoclonal-antibody (5652) 5652
pharmacology & pharmacy (5430) 5430
research (5426) 5426
chemotherapy (5317) 5317
rituximab (5310) 5310
infliximab (5299) 5299
antibodies, monoclonal, humanized - therapeutic use (5229) 5229
mice (5014) 5014
drug therapy (5007) 5007
hematology (4747) 4747
health aspects (4702) 4702
clinical trials (4648) 4648
antibodies, monoclonal, humanized - adverse effects (4607) 4607
medicine & public health (4513) 4513
antineoplastic combined chemotherapy protocols - therapeutic use (4325) 4325
bevacizumab (4259) 4259
safety (4217) 4217
antineoplastic agents - therapeutic use (4195) 4195
analysis (4139) 4139
aged, 80 and over (4112) 4112
double-blind (4081) 4081
patients (4059) 4059
rheumatology (3812) 3812
adolescent (3636) 3636
risk factors (3603) 3603
efficacy (3528) 3528
retrospective studies (3527) 3527
transplantation (3486) 3486
antineoplastic agents - adverse effects (3441) 3441
tumor necrosis factor-alpha - antagonists & inhibitors (3230) 3230
proteins (3217) 3217
antibodies, monoclonal, humanized - administration & dosage (3150) 3150
young adult (3129) 3129
medicine, research & experimental (3086) 3086
medical research (3025) 3025
abridged index medicus (3003) 3003
expression (2948) 2948
tumors (2947) 2947
surgery (2938) 2938
disease (2928) 2928
immunosuppressive agents - therapeutic use (2897) 2897
follow-up studies (2768) 2768
antineoplastic combined chemotherapy protocols - adverse effects (2749) 2749
time factors (2732) 2732
rheumatoid arthritis (2712) 2712
clinical trials as topic (2693) 2693
antigens (2643) 2643
arthritis, rheumatoid - drug therapy (2630) 2630
immunoglobulins (2590) 2590
metastasis (2568) 2568
medicine, general & internal (2516) 2516
dermatology (2506) 2506
antibody (2504) 2504
drug therapy, combination (2483) 2483
adalimumab (2475) 2475
antibodies, monoclonal - pharmacology (2470) 2470
trial (2463) 2463
prognosis (2400) 2400
child (2394) 2394
studies (2392) 2392
rheumatoid-arthritis (2379) 2379
inflammation (2357) 2357
cytokines (2348) 2348
internal medicine (2289) 2289
antirheumatic agents - therapeutic use (2202) 2202
dose-response relationship, drug (2192) 2192
antibodies, monoclonal - immunology (2186) 2186
review (2176) 2176
gastroenterology & hepatology (2171) 2171
viral antibodies (2170) 2170
survival (2145) 2145
medicine (2142) 2142
drug administration schedule (2141) 2141
disease-free survival (2134) 2134
lymphocytes (2131) 2131
etanercept (2103) 2103
antirheumatic agents - adverse effects (2057) 2057
prospective studies (2042) 2042
monoclonal-antibodies (2041) 2041
antibodies, monoclonal, murine-derived (1958) 1958
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (59026) 59026
German (482) 482
Japanese (447) 447
French (434) 434
Spanish (269) 269
Chinese (131) 131
Italian (68) 68
Russian (51) 51
Danish (45) 45
Polish (44) 44
Dutch (34) 34
Hungarian (29) 29
Portuguese (28) 28
Czech (22) 22
Swedish (19) 19
Norwegian (15) 15
Finnish (10) 10
Korean (10) 10
Hebrew (8) 8
Croatian (7) 7
Turkish (5) 5
Serbian (3) 3
Arabic (2) 2
Romanian (2) 2
Slovak (2) 2
Bulgarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 8, pp. 745 - 755
.... This placebo-controlled study investigated the effects of denosumab, a fully human monoclonal antibody against the receptor activator of nuclear factor-κ... 
ZOLEDRONIC ACID | FRACTURE | MEDICINE, GENERAL & INTERNAL | PLACEBO | BONE-MINERAL DENSITY | RISK | COMPLICATIONS | RANDOMIZED CONTROLLED-TRIAL | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2012, Volume 308, Issue 23, pp. 2497 - 2506
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 21, pp. 2691 - 2697
.... We review the literature on managing the adverse effects and kinetics of tumor regression with ipilimumab and provide guidelines on their management... 
REGRESSION | METASTATIC MELANOMA | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | EFFICACY | ONCOLOGY | PHASE-II | MONOCLONAL-ANTIBODY | CTLA-4 | PATIENT | CANCER-IMMUNOTHERAPY | BLOCKADE | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 10/2015, Volume 173, Issue 4, pp. 930 - 939
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 12, pp. 1108 - 1118
A monoclonal antibody to PCSK9 was studied in two single-dose trials in healthy volunteers and one multiple-dose trial in patients with familial or nonfamilial hypercholesterolemia... 
POPULATION | MEDICINE, GENERAL & INTERNAL | STATIN | MICE | MUTATIONS | Proprotein Convertases - antagonists & inhibitors | Injections, Intravenous | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Hypercholesterolemia - drug therapy | Dose-Response Relationship, Drug | Injections, Subcutaneous | Serine Endopeptidases - immunology | Adult | Cholesterol, LDL - blood | Female | Hyperlipoproteinemia Type II - drug therapy | Drug Therapy, Combination | Pyrroles - therapeutic use | Proprotein Convertases - metabolism | Receptors, LDL - metabolism | Lipoproteins - blood | Anticholesteremic Agents - adverse effects | Proprotein Convertases - immunology | Hyperlipoproteinemia Type II - metabolism | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Least-Squares Analysis | Serine Endopeptidases - metabolism | Receptors, LDL - drug effects | Hypercholesterolemia - metabolism | Proprotein Convertase 9 | Drugs | Dose-response relationship (Biochemistry) | Hypercholesterolemia | Monoclonal antibodies | Cholesterol, LDL | Dosage and administration | Product/Service Evaluations | Research | Drug therapy | Health aspects | Studies | Lipoproteins (low density) | Kexin | Serine | Atorvastatin | Cardiovascular disease | Subtilisin | Low density lipoprotein | Cholesterol
Journal Article